Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Thalidomide for therapy of refractory multiple myeloma

Jan. 11, 2000

Depot avorelin produces effective, sustained and safe medical castration in prostate cancer

Jan. 10, 2000

Korean lab focuses on fumagillol derivatives as angiogenesis inhibitors

Jan. 10, 2000

Novel Pfizer compounds useful for hyperproliferative disorders

Jan. 5, 2000

International patent covers new antiangiogenic compounds in development at Abbott

Jan. 4, 2000

Tanabe Seiyaku discovers three new 20S proteasome inhibitors produced by actinomycetes

Jan. 4, 2000

Naturally occurring resorcylic acid lactone as potent and selective MEK inhibitor

Jan. 4, 2000

LY-329146 reverses MRP1- and also P-glycoprotein-associated MDR in cancer cells

Jan. 4, 2000

Retinoids with antineoplastic activity designed at Ligand

Jan. 4, 2000

Antiangiogenic activity of troponin I may involve direct inhibition of bFGF and VEGF receptors

Jan. 3, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...